As of 2026, this quarterly research review offers essential intelligence across multiple segments of the life sciences sector, including pharmaceuticals, biopharmaceuticals, medical devices, and cell biology. It provides a thorough overview of the current life sciences landscape, focusing on key market trends, emerging growth opportunities, and regulatory updates. The report emphasizes sustainability metrics and investment flows, supported by advanced data visualizations that illustrate market size. It also highlights customized research capabilities, including syndicated studies, quantitative analysis reports, and targeted solutions designed to address specific industry challenges. This comprehensive analysis is crucial for understanding the impact of strategic mergers on product pipelines and the effects of patent expirations on the industry.
Below is a list of reports published in the third quarter of 2026.
Below is a list of reports published in the third quarter of 2026.
- BIO277A Global HLA Typing for Transplant Market
- BIO176B Current Bioprinting Prospects and Future Innovations: Global Markets
- BIO145C The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
- BIO278A Global Gene Transfer Technologies Market
- BIO279A Global Peripheral Blood Mononuclear Cells Market
- HLC210B Cardiovascular Devices: Global Markets to 2030
- HLC208B Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare
- HLC205B Global Markets and Technologies for Electronic Health Records
- HLC317A Global Pathology Services Market
- HLC238B Liquid Biopsy with Emphasis on Cancer: Global Markets to 2031
- HLC046G Intravenous (IV) Therapy and Vein Access: Global Markets
- MDS113A Global Veterinary Medical Devices Market
- MDS016B Outpatient Surgical Procedures: Global Markets
- PHM210B Blood Cancer Therapeutics: Global Markets to 2023
- PHM292A Global Topical Drug Delivery Market
- PHM293A Global Vaccine Adjuvants Market
Table of Contents
Chapter 1 Industry Lens on Transformation and Growth
Chapter 2 Medical Devices and Surgical - Quarterly Review
Chapter 3 Executive Summary of MDS016B - Outpatient Surgical Procedures: Global Markets
Chapter 4 Executive Summary of MDS113A - Global Veterinary Medical Devices Market
Chapter 5 Cell Biology - Quarterly Review
Chapter 6 Executive Summary of BIO277A - Global HLA Typing for Transplant Market
Chapter 7 Executive Summary of BIO176B - Current Bioprinting Prospects and Future Innovations: Global Markets
Chapter 8 Executive Summary of BIO145C - The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
Chapter 9 Executive Summary of BIO278A - Global Gene Transfer Technologies Market
Chapter 10 Executive Summary of BIO279A - Global Peripheral Blood Mononuclear Cells Market
Chapter 11 Pharmaceuticals - Quarterly Review
Chapter 12 Executive Summary of PHM210B- Blood Cancer Therapeutics: Global Markets to 2030
Chapter 13 Executive Summary of PHM292A - Global Topical Drug Delivery Market
Chapter 14 Executive Summary of PHM293A - Global Vaccine Adjuvants Market
Chapter 15 Health Maintenance - Quarterly Review
Chapter 16 Executive Summary of HLC210B - Cardiovascular Devices: Global Markets to 2030
Chapter 17 Executive Summary of HLC208B- Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare
Chapter 18 Executive Summary of HLC205B - Global Markets and Technologies for Electronic Health Records
Chapter 19 Executive Summary of HLC317A - Global Pathology Services Market
Chapter 20 Executive Summary of HLC238B - Liquid Biopsy with Emphasis on Cancer: Global Markets to 2031
Chapter 21 Executive Summary of HLC046G - Intravenous (IV) Therapy and Vein Access: Global Markets
Chapter 22 Upcoming Reports
List of Tables
List of Figures
Executive Summary
- The global market for bioprinting is expected to grow from $2.4 billion in 2025 and is projected to reach $5.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.1% during the forecast period of 2025 to 2030.
- The global market for peripheral blood mononuclear cells (PBMCs) was valued at $322.2 million in 2025 and, is estimated to reach $353.9 million by 2026 and $577.2 million by 2031, at a compound annual growth rate (CAGR) of 10.3% from 2026 through 2031.
- The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.
